Literature DB >> 17997978

Glucose-dependent active ATP depletion by koningic acid kills high-glycolytic cells.

Shohei Kumagai1, Ritsuko Narasaki, Keiji Hasumi.   

Abstract

Many types of cancer cells depend heavily on glycolysis for energy production even in aerobic conditions. We found that koningic acid (KA), an inhibitor of glyceraldehyde-3-phosphate dehydrogenase (GAPDH), selectively kills high-glycolytic cells through glucose-dependent active ATP deprivation. Out of seven tumor cell lines tested, growth of six cell lines, which had high glycolytic capacity, was inhibited by KA, whereas three normal cell lines, which had low glycolytic activity, were insensitive to KA. The growth inhibition and caspase-independent cell death in sensitive cells were related to severe ATP depletion that was promoted by glucose phosphorylation. Although GAPDH was completely inhibited in KA-insensitive CHO-K1 cells, KA-mediated ATP depletion was less extensive and transient, possibly due to utilization of ketogenic essential amino acids as energy source. KA suppressed Ehrlich ascites tumor growth in vivo and benefited the survival of the affected mice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17997978     DOI: 10.1016/j.bbrc.2007.10.199

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  21 in total

1.  Molecular Pathways: Targeting Cellular Energy Metabolism in Cancer via Inhibition of SLC2A1 and LDHA.

Authors:  Aik T Ooi; Brigitte N Gomperts
Journal:  Clin Cancer Res       Date:  2015-04-02       Impact factor: 12.531

2.  Hacking hexokinase halts tumor growth.

Authors:  Yongjun Fan; Wei-Xing Zong
Journal:  Cancer Biol Ther       Date:  2008-06-30       Impact factor: 4.742

Review 3.  Metabolic targets for cancer therapy.

Authors:  Lorenzo Galluzzi; Oliver Kepp; Matthew G Vander Heiden; Guido Kroemer
Journal:  Nat Rev Drug Discov       Date:  2013-10-11       Impact factor: 84.694

4.  Evolved resistance to partial GAPDH inhibition results in loss of the Warburg effect and in a different state of glycolysis.

Authors:  Maria V Liberti; Annamarie E Allen; Vijyendra Ramesh; Ziwei Dai; Katherine R Singleton; Zufeng Guo; Jun O Liu; Kris C Wood; Jason W Locasale
Journal:  J Biol Chem       Date:  2019-11-20       Impact factor: 5.157

5.  Nuclear retention of importin α coordinates cell fate through changes in gene expression.

Authors:  Yoshinari Yasuda; Yoichi Miyamoto; Tomoko Yamashiro; Munehiro Asally; Ayumi Masui; Chin Wong; Kate L Loveland; Yoshihiro Yoneda
Journal:  EMBO J       Date:  2011-09-30       Impact factor: 11.598

Review 6.  Anticancer agents that counteract tumor glycolysis.

Authors:  Carlotta Granchi; Filippo Minutolo
Journal:  ChemMedChem       Date:  2012-06-08       Impact factor: 3.466

7.  Pyruvate remediation of cell stress and genotoxicity induced by haloacetic acid drinking water disinfection by-products.

Authors:  Azra Dad; Clara H Jeong; Justin A Pals; Elizabeth D Wagner; Michael J Plewa
Journal:  Environ Mol Mutagen       Date:  2013-07-26       Impact factor: 3.216

Review 8.  Cancer cell metabolic plasticity in migration and metastasis.

Authors:  Jenna A Mosier; Samantha C Schwager; David A Boyajian; Cynthia A Reinhart-King
Journal:  Clin Exp Metastasis       Date:  2021-06-02       Impact factor: 5.150

9.  Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is pyruvylated during 3-bromopyruvate mediated cancer cell death.

Authors:  Shanmugasundaram Ganapathy-Kanniappan; Jean-Francois H Geschwind; Rani Kunjithapatham; Manon Buijs; Josephina A Vossen; Irina Tchernyshyov; Robert N Cole; Labiq H Syed; Pramod P Rao; Shinichi Ota; Mustafa Vali
Journal:  Anticancer Res       Date:  2009-12       Impact factor: 2.480

10.  GAPDH binds to active Akt, leading to Bcl-xL increase and escape from caspase-independent cell death.

Authors:  M A Jacquin; J Chiche; B Zunino; M Bénéteau; O Meynet; L A Pradelli; S Marchetti; A Cornille; M Carles; J-E Ricci
Journal:  Cell Death Differ       Date:  2013-05-03       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.